Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 3/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.35 |
| ▸ | TYMS | P04818 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | CASP1 | P29466 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | CES1 | P23141 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.33 |
| ▸ | DHFR | P00374 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26557664 | 0.88 | CES1 (0.37) | CYP2D6CYP2C19PDK2ALDH1A1HSD17B10 | |
| SCHEMBL23287614 | 0.83 | PDK2 (0.36) | CYP2D6CYP2C19PDK2ALDH1A1HSD17B10 | |
| SCHEMBL19152537 | 0.81 | CAMK2D (0.36) | ALDH1A1HSD17B10MAPK1HPGDHIF1A | |
| SCHEMBL26399498 | 0.81 | TRPM4 (0.42) | PDK2ALDH1A1HSD17B10MAPK1HPGD | |
| SCHEMBL20582020 | 0.81 | ALDH1A1 (0.36) | PDK2ALDH1A1HSD17B10MAPK1HPGD | |
| SCHEMBL26380587 | 0.81 | PDK2 (0.38) | PDK2ALDH1A1HSD17B10MAPK1HPGD | |
| SCHEMBL22000314 | 0.79 | PDK2 (0.40) | CYP2D6CYP2C19PDK2ALDH1A1HSD17B10 | |
| SCHEMBL23287616 | 0.79 | DHFR (0.34) | CYP2D6CYP2C19PDK2ALDH1A1HSD17B10 | |
| SCHEMBL23288325 | 0.77 | PRKCZ (0.40) | PDK2ALDH1A1HSD17B10MAPK1HPGD | |
| SCHEMBL30038894 | 0.76 | PDK2 (0.45) | PDK2ALDH1A1TYMSL3MBTL1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12415823-B2 | Heterocyclic compound and organic light-emitting device comprising same | LT MATERIALS CO., LTD. (KR) | 2025-09-16 | — | — | US | disclosed |
| EP-4050001-B1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO LTD (KR) | 2025-05-21 | — | — | EP | disclosed |
| US-11711973-B2 | Organic electronic device | DUK SAN NEOLUX CO., LTD. (KR) | 2023-07-25 | — | — | US | disclosed |
| US-11711973-B2 | Organic electronic device | DUK SAN NEOLUX CO., LTD. (KR) | 2023-07-25 | — | — | US | disclosed |
| US-20220289693-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2022-09-15 | — | — | US | disclosed |
| EP-4050001-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT Materials Co., Ltd. (KR) | 2022-08-31 | — | — | EP | disclosed |
| CN-114072383-A | Heterocyclic compound and organic light-emitting element including same | LT素材株式会社 | 2022-02-18 | — | — | CN | disclosed |
| WO-2021080282-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 엘티소재주식회사 | 2021-04-29 | — | — | WO | disclosed |
| WO-2021080282-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 엘티소재주식회사 | 2021-04-29 | — | — | WO | disclosed |
| WO-2020231197-A1 | ORGANIC ELECTRIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRIC ELEMENT, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2020-11-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220289693-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CRY1, CYP1A1, CYP1B1 | CYP2D6 40/4885CYP2C19 10/4885PDK2 1166/4885 |
| US-12415823-B2 | Heterocyclic compound and organic light-emitting device comprising same | CRY1, CYP1A1, CYP1B1 | CYP2D6 40/4885CYP2C19 10/4885PDK2 1166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.